Enblad, Gunilla <br/><br/>
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  12 2018 
 - 6185-6194 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-18-0426  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, CD19--immunology<br/>Batch Cell Culture Techniques<br/>Cell Separation<br/>Female<br/>Humans<br/>Immunity, Cellular<br/>Immunotherapy, Adoptive--adverse effects<br/>Leukemia--diagnosis<br/>Lymphocyte Count<br/>Lymphoma--diagnosis<br/>Male<br/>Middle Aged<br/>Receptors, Antigen, T-Cell--genetics<br/>Recombinant Fusion Proteins--genetics<br/>Survival Analysis<br/>T-Lymphocytes--immunology<br/>Transgenes<br/>Treatment Outcome<br/>Young Adult